Itaconix PLC Result of General Meeting (9713S)
14 Luglio 2020 - 1:52PM
UK Regulatory
TIDMITX
RNS Number : 9713S
Itaconix PLC
14 July 2020
Itaconix plc
("Itaconix" or the "Company")
Result of US Additional Subscription, Result of General Meeting,
Issue of Equity and Total Voting Rights
Itaconix plc (LSE:ITX) (OTCQB:ITXXF) is pleased to announce that
all resolutions were duly passed at the General Meeting held
earlier today at 11.30 a.m. (UK time) in connection with the
Fundraising announced by the Company on 23 June 2020. The Company
also announces that GBP36,500 has been raised pursuant to the US
Additional Subscription.
Accordingly, the Company has raised, in aggregate, gross
proceeds of approximately GBP1.8 million pursuant to the
Fundraising .
John R. Shaw, CEO of Itaconix, stated: "I appreciate the support
of our existing shareholders and welcome new shareholders on our
mission to deliver next generation consumer products based on our
bio-based ingredients that are safer, have better performance, and
are more sustainable. As we gain commercial momentum in key
markets, completion of the Fundraising opens a new phase in the
Company's growth. I look forward to updating the market on our
progress."
Issue of Equity and Total Voting Rights
A total of 151,769,048 new Ordinary Shares are therefore being
issued and allotted, comprising 138,266,775 Second Placing Shares,
10,184,091 Subscription Shares and 3,318,182 US Additional
Subscription Shares. Application has been made to the London Stock
Exchange for the Second Placing Shares, the Subscription Shares and
the US Additional Subscription Shares, all of which are being
credited as fully paid and will be identical to and rank pari passu
in all respects with the existing Ordinary Shares, to be admitted
to trading on AIM ("Admission"). It is expected that Admission will
become effective and dealings will commence at 8.00 a.m. on 15 July
2020.
Following Admission, the issued share capital of the Company
will consist of 432,448,253 Ordinary Shares, with one voting right
each. The above figures may be used by shareholders in the Company,
following completion of the Fundraising as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Capitalised terms used in this announcement shall, unless
otherwise stated, bear the same meaning ascribed to such terms in
the announcement made by the Company on 23 June 2020 to announce
the launch of the Fundraising.
Itaconix Plc +1 (603) 775 4400
John R . Shaw, Chief Executive Officer
Laura Denner, Chief Financial Officer
and Company Secretary
www.Itaconix.com
N+1 Singer (Nominated Adviser and Joint
Broker) +44 (0) 207 496 3000
Peter Steel / James Moat
Tom Salvesen
Allenby Capital Limited (Joint Broker
- Placing) +44 (0) 203 328 5656
Amrit Nahal (Broking)
Nick Athanas / Liz Kirchner (Corporate
Finance)
About Itaconix
Itaconix plc is a leading innovator in bio-based functional
ingredients for improving the safety and performance of homecare,
personal care, and industrial products. Its proprietary polymer
technology generates a growing range of new ingredients with unique
functionality that meet consumer demands for value and
sustainability.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ROMDZGMNMDLGGZM
(END) Dow Jones Newswires
July 14, 2020 07:52 ET (11:52 GMT)
Grafico Azioni Itaconix (LSE:ITX)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Itaconix (LSE:ITX)
Storico
Da Apr 2023 a Apr 2024